Novo Nordisk | NVO - Current Liabilities

Stock Price
59.00
Daily Change
-0.33 -0.56%
Monthly
15.98%
Yearly
-30.09%
Q1 Forecast
56.42

Novo Nordisk reported DKK32.79B in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
ANI Pharmaceuticals USD 270.56M 33.72M Sep/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
Bausch Health Companies USD 4.79B 182M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Corcept Therapeutics USD 172.26M 27.6M Sep/2025
Drreddys Laboratories INR 1.76B 62.5M Dec/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Novo Nordisk DKK 234.36B 26.84B Sep/2025
Novo Nordisk DKK 32.79B 203.33B Jun/2025
Pacira USD 107.08M 206.09M Sep/2025
Perrigo USD 1.15B 19.2M Sep/2025
Prestige Brands USD 134.6M 24.94M Sep/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Supernus Pharmaceuticals USD 330.63M 44.27M Sep/2025
Zoetis USD 1.81B 1.56B Sep/2025